Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Graduate Teaching Assistant

Pharmacology · Bangladesh · 2025-01-30

Processing Time
207 days
Decision Date
2025-01-30
Location
Wisconsin
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to leverage sophisticated biochemical techniques to investigate the interaction between LSD1 and RNA-DNA hybrids. Her research aims to provide novel insights into molecular mechanisms influencing gene expression and the pathology of Ewing sarcoma, a rare childhood cancer. This work is intended to support the development of targeted therapies with fewer side effects.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses Ewing sarcoma, which presents significant clinical and socioeconomic challenges, aligning with national healthcare innovation priorities.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic record of 7 publications and expert testimonials demonstrate her unique methodologies and proven ability to advance pharmacological science.

3 On Balance, Beneficial to Waive Job Offer/Labor Cert Met

USCIS recognized that waiving the requirements is in the national interest due to her potential to generate new therapeutic strategies for cancer treatment.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 7 peer-reviewed journal articles and 27 citations, demonstrating recognition by experts in pharmacology. The case included two independent recommendation letters and evidence that her work aligns with national healthcare priorities. USCIS determined she satisfied all three Dhanasar prongs, particularly regarding the national importance of Ewing sarcoma research.

Request for Evidence (RFE)

Successfully Addressed

The petitioner received an RFE which was addressed by the law firm through prompt responses and clear evidence. The response successfully demonstrated the merits of the case, leading to approval.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Original Contributions
Government Alignment

Similar Cases

Research Scientist

Healthcare · Vietnam

WeGreened EB-2 (NIW) rfe approved
297 days 2025-01-11
The petitioner proposes to continue her research in medical science by investigating molecular pathways involved in tumor proliferation. Her work focuses on developing targeted inhibitors and antibodies designed to slow or prevent cancer progression and improve patient monitoring in clinical settings.
View Case

Research Fellow

Biotechnology · Russia

WeGreened EB-2 (NIW) approved
Massachusetts 287 days 2025-02-10
The petitioner proposes to continue research in biomedical science with a focus on disease modeling, targeted therapy development, and the molecular characterization of rare tumors. The work involves genomic analysis of pediatric and adult tumors to enable personalized treatments and validate the effectiveness of drugs like seribantumab and zenocutuzumab. The intended impact is to address urgent gaps in oncology and overcome drug resistance mechanisms in under-researched cancers.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Postdoctoral Researcher

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Illinois 535 days 2026-01-16
The petitioner proposes to continue research in clinical pharmaceutical sciences, specifically focusing on understanding cancer development at the molecular level. The work involves investigating mechanisms such as genome instability and replication stress to identify actionable molecular targets for cost-conscious therapeutic strategies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from Bangladesh

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 207 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Bangladesh All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist